NDC 0002-5562-60
RETEVMO 160 mg/1
selpercatinib · TABLET, COATED
RETEVMO is a tablet, coated containing selpercatinib at a strength of 160 mg/1. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- RETEVMO
- Generic Name
- selpercatinib
- NDC Code (Package)
0002-5562-60- NDC Code (Product)
0002-5562- Manufacturer
- Eli Lilly and Company
- Strength
- 160 mg/1
- Dosage Form
- TABLET, COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA218160
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 04/10/2024
Recall History
No Recall HistoryView Full Drug Page
RETEVMO — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.